Comment: “Co-Prescribing of Central Nervous System-Active Medications for COPD Patients: Impact on Emergency Room Visits and Hospitalization”

Sood A Kuo YF Westra J Sharma G Raji MA . Co-prescribing of central nervous system-active medications for COPD patients: impact on emergency room visits and hospitalization [published online ahead of print August 9, 2022]. Ann Pharmacother. doi:10.1177/10600280221113299

Bykov K Bateman BT Franklin JM Vine SM Patorno E . Association of gabapentinoids with the risk of opioid-related adverse events in surgical patients in the United States. JAMA Netw Open. 2020;3(12):e2031647. doi:10.1001/jamanetworkopen.2020.31647

Olopoenia A Camelo-Castillo W Qato DM , et al. Adverse outcomes associated with concurrent gabapentin, opioid, and benzodiazepine utilization: a nested case-control study. Lancet Reg Health Am. 2022;13:100302. doi:10.1016/j.lana.2022.100302

Gomes T Juurlink DN Antoniou T Mamdani MM Paterson JM van den Brink W . Gabapentin, opioids, and the risk of opioid-related death: a population-based nested case-control study. PLoS Med. 2017;14(10):e1002396. doi:10.1371/journal.pmed.1002396

Babu KM Brent J Juurlink DN . Prevention of opioid overdose. N Engl J Med. 2019;380(23):2246-2255. doi:10.1056/NEJMra1807054

U.S. Food and Drug Administration (FDA). FDA warns about serious breathing problems with seizure and nerve pain medicines gabapentin (Neurontin, Gralise, Horizant) and pregabalin (Lyrica, Lyrica CR), 2019. Accessed September 20, 2022. https://www.fda.gov/drugs/drug-safety-and-availability/fda-warns-about-serious-breathing-problems-seizure-and-nerve-pain-medicines-gabapentin-neurontin

IBM Micromedex®. IBM Micromedex solutions. Accessed September 21, 2022. https://www.ibm.com/watson-health/about/micromedex

IBM Micromedex®. Drug interaction checking (electronic version). IBM Watson Health. Accessed September 21, 2022. https://www-micromedexsolutions-com.pallas2.tcl.sc.edu/

U.S. Food and Drug Administration. OXYCONTIN® PACKAGE INSERT, n.d. Accessed September 21, 2022. https://www.accessdata.fda.gov/drugsatfda_docs/label/2008/020553s059lbl.pdf

Parthipan A Banerjee I Humphreys K , et al. Predicting inadequate postoperative pain management in depressed patients: a machine learning approach. PLoS ONE. 2019;14(2):e0210575. doi:10.1371/journal.pone.0210575

Florian J van der Schrier R Gershuny V , et al. Effect of paroxetine or quetiapine combined with oxycodone vs oxycodone alone on ventilation during hypercapnia: a randomized clinical trial. JAMA. 2022;328(14):1405-1414. doi: 10.1001/jama.2022.17735